|
|
Volumn 33, Issue 1, 2015, Pages 3-4
|
|
IL-17-targeting biologics aim to become standard of care in psoriasis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INTERLEUKIN 17;
IXEKIZUMAB;
MONOCLONAL ANTIBODY;
ANTAGONISTS AND INHIBITORS;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
PSORIASIS;
UNITED STATES;
ANTIBODIES, MONOCLONAL, HUMANIZED;
HUMANS;
INTERLEUKIN-17;
PSORIASIS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84942097859
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0115-3 Document Type: Note |
|
Times cited : (16)
|
|
References (0)
|